Bracco Diagnostics has opened a new research center in Plan-Les-Ouates, an area on the outskirts of Geneva, Switzerland, where several new high-technology firms are sprouting up. The center will house Bracco Research, a unit of the company’s
Bracco Diagnostics has opened a new research center in Plan-Les-Ouates, an area on the outskirts of Geneva, Switzerland, where several new high-technology firms are sprouting up.
The center will house Bracco Research, a unit of the companys research and development division and Bracco Imaging, a new manufacturing plant. The plant will produce Braccos new ultrasound contrast agent, SonoVue.
The facility in Plan-Les-Ouates is part of the Milan-based companys research network, which includes advanced research centers in Milan and Princeton, NJ. Bracco will earmark a projected $95 million, or 190 billion lira, in 2000 for the new research and development center. Bracco also operates production centers in Milan and Ceriano Laghetto. Another new manufacturing plant will open soon in Torviscosa.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.